Category: Uncategorized

Eli Lilly and Company has officially announced definitive data from its global Phase 3 BRUIN CLL-322 clinical trial. The landmark... Read more

SK Life Science, Inc. (a Paramus, New Jersey-based biopharmaceutical enterprise and a subsidiary of South Korea's SK Biopharmaceuticals Co., Ltd.)... Read more

Novartis India has officially announced the commercial launch of Pluvicto, marking the country’s premier regulatory-approved radioligand therapy (RLT) indicated for... Read more

Merck & Co. (operating as MSD outside the United States and Canada) has secured formal marketing approval from the U.S.... Read more

Simcere Pharmaceutical Group has formalized a strategic research collaboration agreement with Stanford Medicine to discover and develop novel therapeutic interventions... Read more

Australian pharmaceutical wholesaler and retailer Sigma Healthcare has formally dropped its pursuit of United Kingdom pharmacy chain Boots, declaring that... Read more

Federal health authorities have announced that Nara Organics has initiated a nationwide recall of its organic infant formula products distributed... Read more

Johnson & Johnson (J&J) has officially announced clinical Phase 3 data validating that a combination of its oncology mainstay Darzalex... Read more